Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders

Publisher： Karger

E-ISSN： 1421-9875|33|3|433-439

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.3, 2015-05, pp. : 433-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 288-292

Karger

Access to resources Recommend Favorite

Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 282-287

Karger

Access to resources Recommend Favorite

Ursodeoxycholic acid and histological progression in primary biliary cirrhosis

By Chan C.-W.   V. Papatheodoridis G.   Goulis J.   K. Burroughs A.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1094-1095

Elsevier

Access to resources Recommend Favorite

Effects of Ursodeoxycholic Acid on Splanchnic and Systemic Hemodynamics

By  

Digestion, Vol. 61, Iss. 2, 2000-02 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Does Ursodeoxycholic Acid Change the Proliferation of the Colorectal Mucosa?

By  

Digestion, Vol. 68, Iss. 4, 2004-02 ,pp. : 209-216

Karger

Access to resources Recommend Favorite